﻿<?xml version="1.0" encoding="utf-8"?><rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/"><channel><title>Cision News</title><link>https://news.cision.com</link><description>Cision is the leading global provider of media research, distribution, monitoring and evaluation services. With over 40 locations throughout the world, Cision provides the insight, expertise and intelligence that improve performance and build reputations.</description><pubDate>Tue, 09 Jun 2026 09:03:09 GMT</pubDate><image><title>Cision News</title><width>146</width><height>60</height><link>https://news.cision.com</link><url>https://news.cision.com/Content/img/news-logo.png</url></image><item><title>Galderma declares its offer for Q-Med unconditional and will acquire all tendered shares</title><link>http://news.cision.com/galderma/r/galderma-declares-its-offer-for-q-med-unconditional-and-will-acquire-all-tendered-shares,c549865</link><guid isPermaLink="false">cision300965</guid><description><![CDATA[This press release may not, directly or indirectly, be distributed or published in the United States, Australia, Japan, Canada, New Zealand, Hong Kong or South Africa. The offer is not being made to (and acceptances will not be accepted from) persons in those countries or elsewhere where their participation requires further documentation, filings or other measures in addition to those required by Swedish law.

Press release

25 February 2011

Please click on the following link to see the full press release: http://bit.ly/gfSpRH

(If the link is not clickable, copy and paste it into]]></description><pubDate>Fri, 25 Feb 2011 14:30:00 GMT</pubDate></item><item><title>Galderma’s offer for Q-Med: Supplement to offer document made public</title><link>http://news.cision.com/galderma/r/galderma-s-offer-for-q-med--supplement-to-offer-document-made-public,c546644</link><guid isPermaLink="false">cision298873</guid><description><![CDATA[This press release may not, directly or indirectly, be distributed or published in the United States, Australia, Japan, Canada, New Zealand, Hong Kong or South Africa. The offer is not being made to (and acceptances will not be accepted from) persons in those countries or elsewhere where their participation requires further documentation, filings or other measures in addition to those required by Swedish law.

Press release

11 February 2011

Please click on the following link to see the full press release: http://bit.ly/ez6AMt

(If the link is not clickable, copy and paste it into]]></description><pubDate>Fri, 11 Feb 2011 16:00:00 GMT</pubDate></item><item><title>Galderma has received all necessary clearances from relevant competition authorities to acquire Q-Med</title><link>http://news.cision.com/galderma/r/galderma-has-received-all-necessary-clearances-from-relevant-competition-authorities-to-acquire-q-med,c546555</link><guid isPermaLink="false">cision298802</guid><description><![CDATA[This press release may not, directly or indirectly, be distributed or published in the United States, Australia, Japan, Canada, New Zealand, Hong Kong or South Africa. The offer is not being made to (and acceptances will not be accepted from) persons in those countries or elsewhere where their participation requires further documentation, filings or other measures in addition to those required by Swedish law.

Press release

11 February 2011

Please click on the following link to see the full press release: http://bit.ly/gRch6V

(If the link is not clickable, copy and paste it into]]></description><pubDate>Fri, 11 Feb 2011 12:00:00 GMT</pubDate></item><item><title>Galderma increases cash offer to SEK 79 per share in Q-Med and extends offer period</title><link>http://news.cision.com/galderma/r/galderma-increases-cash-offer-to-sek-79-per-share-in-q-med-and-extends-offer-period,c545682</link><guid isPermaLink="false">cision298052</guid><description><![CDATA[This press release may not, directly or indirectly, be distributed or published in the United States, Australia, Japan, Canada, New Zealand, Hong Kong or South Africa. The offer is not being made to (and acceptances will not be accepted from) persons in those countries or elsewhere where their participation requires further documentation, filings or other measures in addition to those required by Swedish law.

Press release

10 February 2011

Galderma increases cash offer to SEK 79 per share in Q-Med and extends offer period

Please click on the following link to see the full press]]></description><pubDate>Thu, 10 Feb 2011 07:30:00 GMT</pubDate></item><item><title>Galderma’s offer for Q-Med: Offer document made public</title><link>http://news.cision.com/galderma/r/galderma-s-offer-for-q-med--offer-document-made-public,c535750</link><guid isPermaLink="false">cision290526</guid><description><![CDATA[This press release may not, directly or indirectly, be distributed or published in the United States, Australia, Japan, Canada, New Zealand, Hong Kong or South Africa. The offer is not being made to (and acceptances will not be accepted from) persons in those countries or elsewhere where their participation requires further documentation, filings or other measures in addition to those required by Swedish law.
Please click on the following link to see the full press release: http://bit.ly/fu5ZDe

(If the link is not clickable, copy and paste it into your browser.)

Galderma Pharma SA]]></description><pubDate>Mon, 03 Jan 2011 14:30:00 GMT</pubDate></item></channel></rss>